AI assistant
biote Corp. — Director's Dealing 2024
May 23, 2024
33946_dirs_2024-05-23_3c3cd3b5-4240-4e69-a8fd-1608a17fbf6d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: biote Corp. (BTMD)
CIK: 0001819253
Period of Report: 2024-05-21
Reporting Person: Jacoby Dana Lynn (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-21 | Class A Common Stock | M | 11595.00 | — | Acquired | 50970.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-21 | Deferred Settlement RSU | $ | M | 11595.00 | Disposed | Class A Common Stock (11595.00) | Direct | |
| 2024-05-21 | Deferred Settlement RSU | $ | A | 12994.00 | Acquired | Class A Common Stock (12994.00) | Direct | |
| 2024-05-21 | Stock Option (Right to Buy) | $5.57 | A | 65258.00 | Acquired | 2034-05-20 | Class A Common Stock (65258.00) | Direct |
Footnotes
F1: Each Deferred Settlement RSU is the economic equivalent of one share of Issuer Class A Common Stock.
F2: The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2024 or the date of the Reporting Person's separation from service.
F3: The Deferred Settlement RSUs are fully vested upon grant, but settlement will be deferred until the earlier of calendar year 2025 or the date of the Reporting Person's separation from service.
F4: All shares subject to the option award shall vest on the earlier of May 21, 2025 or the day prior to the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.